TNXPTonix Pharmaceuticals Holdi...

Nasdaq tonixpharma.com


$ 0.50 $ 0.01 (2.9 %)    

Wednesday, 31-Jul-2024 15:58:56 EDT
QQQ $ 457.29 $ -11.41 (-2.42 %)
DIA $ 403.27 $ -5.26 (-1.29 %)
SPY $ 541.71 $ -7.80 (-1.42 %)
TLT $ 95.61 $ 0.50 (0.53 %)
GLD $ 225.83 $ -0.78 (-0.34 %)
$ 0.5105
$ 0.51 x 100
-- x --
-- - --
$ 0.46 - $ 35.20
1,676,289
na
1.29M
$ -0.08
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 03-13-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 03-14-2022 12-31-2021 10-K
11 11-08-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 03-15-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-12-2020 03-31-2020 10-Q
18 03-24-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-12-2019 06-30-2019 10-Q
21 05-13-2019 03-31-2019 10-Q
22 03-18-2019 12-31-2018 10-K
23 11-09-2018 09-30-2018 10-Q
24 08-13-2018 06-30-2018 10-Q
25 05-11-2018 03-31-2018 10-Q
26 03-09-2018 12-31-2017 10-K
27 11-06-2017 09-30-2017 10-Q
28 08-11-2017 06-30-2017 10-Q
29 05-12-2017 03-31-2017 10-Q
30 04-13-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-05-2016 06-30-2016 10-Q
33 05-06-2016 03-31-2016 10-Q
34 03-03-2016 12-31-2015 10-K
35 11-06-2015 09-30-2015 10-Q
36 08-07-2015 06-30-2015 10-Q
37 05-08-2015 03-31-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 11-07-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 tonix-pharmaceuticals-fibromyalgia-treatment-receives-fda-fast-track-designation

The FDA has granted Tonix Pharmaceuticals (NASDAQ:TNXP) a fully integrated biopharmaceutical company Fast Track designation for...

 tonix-pharmaceuticals-announces-potential-impact-of-the-us-national-academies-new-definition-of-long-covid-on-the-size-of-the-fibromyalgia-market-for-tonmya

Fibromyalgia is a "diagnosable condition" in people suffering from Long COVID according to NASEM1 Diagnosing fibromyalg...

 alliance-global-partners-maintains-buy-on-tonix-pharmaceuticals-raises-price-target-to-11

Alliance Global Partners analyst James Molloy maintains Tonix Pharmaceuticals (NASDAQ:TNXP) with a Buy and raises the price ...

 tonix-pharmaceuticals-set-to-file-an-nda-for-tonmya-for-the-management-of-fibromyalgia-assuming-approval-by-the-fda-in-2h-2025

With the completion of its final pre-NDA meeting with the FDA, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced it i...

 tonix-pharmaceuticals-intends-to-offer-and-sell-shares-of-its-common-stock-or-pre-funded-warrants-in-lieu-thereof

All of the securities to be sold in the offering are to be offered by Tonix. The Company intends to use the net proceeds from t...

 why-tonix-pharmaceuticals-tnxp-stock-is-falling

Tonix Pharmaceuticals shares are trading lower by 11.3% during Monday's session. The company announced receipt of the forma...

 tonix-pharmaceuticals-reports-final-pre-nda-meeting-with-fda-for-tonmya-for-management-of-fribromyalgia

Tonmya is a potential new first-line, centrally acting non-opioid analgesic for the management of fibromyalgia Approximately 10...

 nano-cap-tonix-pharmaceuticals-secures-large-us-department-of-defense-contract

Tonix Pharmaceuticals secures a potential $34 million agreement with the Defense Threat Reduction Agency to develop antiviral a...

 nike-micron-and-3-stocks-to-watch-heading-into-thursday

With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as fo...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION